Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Srinivas Akkaraju Net Worth & Insider Trades

Srinivas Akkaraju - Director, Syros Pharmaceuticals, Inc

As of September 19, 2023

What is Srinivas Akkaraju's Net Worth?

The current estimated net worth of Syros Pharmaceuticals, Inc's Director, Srinivas Akkaraju, is estimated to be about $352.18M . Srinivas Akkaraju owns about 1,274,616 units of Syros Pharmaceuticals, Inc common stock. In the last 6 years at Syros Pharmaceuticals, Inc, Srinivas Akkaraju has sold an estimated value of $3.86M worth.

What is Srinivas Akkaraju's Past Insider Trading?

Srinivas Akkaraju's largest purchase order was 533,332 units , worth over $4M on April 11, 2019. Srinivas Akkaraju's largest sale order was 159,327 units , worth over $2.09M on August 19, 2020. In total, Srinivas Akkaraju has made about 16 transactions over 6 years of their time at Syros Pharmaceuticals, Inc. Srinivas Akkaraju usually trades in June, with the busiest year in 2020.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

SRINIVAS AKKARAJU

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Srinivas Akkaraju's' Mailing Address?

  • Mailing address is 565 Everett Avenue Palo Alto CA 94301 CA

What are Syros Pharmaceuticals, Inc's Past Insider Trades?

Syros Pharmaceuticals, Inc's most recent insider trade came on August 2, 2023 by David Roth who sold 7,348 units worth $29.02K . In the last 7 years, insiders at Syros Pharmaceuticals, Inc have sold an estimated value of $8.81M and bought an estimated value of $48.37M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Richard Young, Director,  Eric Olson, Chief Scientific Officer,  and Nancy Simonian, President & CEO .

Syros Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...